From Inflammation to Targeted Therapy: Leveraging Neutrophil, Platelet, RBC, and Macrophage Biology for Nanocarrier in Atherosclerosis

Current Atherosclerosis Reports 2026

View at publisher

Authors: Farshad Heydari, Michael R. Hamblin, Jalal Naghinezhad

DOI: 10.1007/s11883-026-01394-3

Cited by: 6

References: 111

Fields of Study & Subjects

Nanoplatforms for cancer theranostics Phagocytosis and Immune Regulation Immune cells in cancer

References 111